Nonmedication Devices in Development for the Treatment of Alzheimer's Disease

被引:0
|
作者
Sleem, Tamara [1 ]
Decourt, Boris [2 ]
Sabbagh, Marwan N. [1 ]
机构
[1] Barrow Neurol Inst, St Josephs Hosp & Med Ctr, Dept Neurol, Phoenix, AZ USA
[2] Texas Tech Univ Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; clinical trials; devices; treatment; DEEP BRAIN-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE-STIMULATION; COGNITIVE FUNCTION; SYNAPTIC PLASTICITY; CORTEX EXCITABILITY; DOUBLE-BLIND; PHOTOBIOMODULATION; CONNECTIVITY; DEMENTIA;
D O I
10.3233/ADR-230115
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huge investments continue to be made in treatment for Alzheimer's disease (AD), with more than one hundred drugs currently in development. Pharmacological approaches and drug development, particularly those targeting amyloid-beta, have dominated the therapeutic landscape. At the same time, there is also a growing interest in devices for treating AD. This review aimed to identify and describe devices under development for AD treatment. In this review, we queried the devices that are in development for the treatment of AD. PubMed was searched through the end of 2021 using the terms "device," "therapeutics," and "Alzheimer's" for articles that report on devices to treat AD. Ten devices with 31 references were identified as actively being developed for the treatment of AD. Many of these devices are far along in development. Device-based therapies are often overlooked when evaluating treatment approaches to AD. However, many devices for treating AD are in development and some show promising results.
引用
收藏
页码:241 / 255
页数:15
相关论文
共 50 条
  • [21] Alzheimer's Disease: Treatment Today and Tomorrow
    Gorthi, Sankar P.
    Gupta, Dulari
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2023, 26 (04) : 326 - 333
  • [22] Advancements in the treatment of agitation in Alzheimer's disease
    Antonsdottir, Inga M.
    Smith, Jessica
    Keltz, Melanie
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (11) : 1649 - 1656
  • [23] Update on the Pharmacological Treatment of Alzheimer's Disease
    Massoud, Fadi
    Gauthier, Serge
    CURRENT NEUROPHARMACOLOGY, 2010, 8 (01) : 69 - 80
  • [24] rTMS for the treatment of Alzheimer's disease: where should we be stimulating?
    Heath, Alesha
    Taylor, J. L.
    McNerney, M. Windy
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (12) : 903 - 905
  • [25] A brief essay on non-pharmacological treatment of Alzheimer's disease
    Raggi, Alberto
    Tasca, Domenica
    Ferri, Raffaele
    REVIEWS IN THE NEUROSCIENCES, 2017, 28 (06) : 587 - 597
  • [26] Treatment of sleep disturbance in Alzheimer's disease
    McCurry, SM
    Reynolds, CF
    Ancoli-Israel, S
    Teri, L
    Vitiello, MV
    SLEEP MEDICINE REVIEWS, 2000, 4 (06) : 603 - 628
  • [27] Is Cognitive Training an Effective Treatment for Preclinical and Early Alzheimer's Disease?
    Gates, Nicola J.
    Sachdev, Perminder
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S551 - S559
  • [28] Cognitive Decline and Treatment of Alzheimer's Disease
    Ignacio Brusco, Luis
    NEUROPSYCHIATRIC DISORDERS, 2010, : 213 - 226
  • [29] Depression in Alzheimer's disease: Overview and treatment
    Lyketsos, CG
    Olin, J
    BIOLOGICAL PSYCHIATRY, 2002, 52 (03) : 243 - 252
  • [30] Alzheimer's Disease Treatment: The Search for a Breakthrough
    Reiss, Allison B.
    Muhieddine, Dalia
    Jacob, Berlin
    Mesbah, Michael
    Pinkhasov, Aaron
    Gomolin, Irving H.
    Stecker, Mark M.
    Wisniewski, Thomas
    De Leon, Joshua
    MEDICINA-LITHUANIA, 2023, 59 (06):